Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
UPDATE: Cantor Fitzgerald Starts BioDelivery Sciences International (BDSI) at Buy
-
Cantor Fitzgerald Starts Organovo Holdings (ONVO) at Buy
-
Cantor Fitzgerald's Apple (AAPL) Barometer Shows Strong Snapback in March
-
FinTech Acquisition Corp. Common Stock And Warrants To Commence Trading Separately On April 6, 2015
-
Keek Announces Terms of Previously Announced Offering
-
BGC Partners (BGCP) Sees Q1 Revenue to Low-End of Prior Outlook ex. GFI Impact
-
BGC Partners Updates Its Outlook for the First Quarter of 2015
-
Notable Analyst Rating Changes 3/31: (DHI) (TEVA) (CNDO) Upgraded; (SLB) (DB) (WPT) Downgraded
-
Pre-Open Stock Movers 03/31: (SORL) (MOV) (CHTR) Higher; (GV) (SNTA) (TCK) Lower (more...)
-
Cantor Fitzgerald Upgrades Immunogen Inc. (IMGN) to Buy; Kadcyla Deal Reduces Overhang
-
Eagle Pharmaceuticals (EGRX) PT Raised to $51 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades Hyperion Therapeutics (HPTX) to Hold Amid Takeover Deal
-
Paramount Gold and Silver Corp. Announces Record Date and Distribution Date For Spin-Off Of Paramount Gold Nevada Corp.
-
MultiVir Files Registration Statement for Proposed Initial Public Offering
-
Cantor Fitzgerald Adds Veterans to Emerging Markets Debt Capital Markets Team
-
Allana Potash Enters Into Arrangement Agreement With ICL
-
Red Hat (RHT) PT Lifted to $85 at Cantor Fitzgerald
-
Attending Firms Announced for the Growth Capital Expo, April 12-14, 2015
-
Phocion Investments Appoints Managing Directors, Kosta Segounis and David Rowen to Its Growing Platform
-
Netflix (NFLX) the Clear Winner in an Unbundled TV World - Cantor Fitzgerald; PT to $500
-
MEI Pharma (MEIP) PT Cut to $7 at Cantor Fitzgerald; 'Buy' Maintained
-
Apple (AAPL) PT Raised to $180 at Cantor Fitzgerald
-
Flex Pharm (FLKS) PT Raised to $27 at Cantor Fitzgerald Ahead of Consumer Product Launch
-
Oracle (ORCL) Lower Into Earnings After the Close
-
Paramount Gold and Silver Corp. Transaction Update
-
Eagle Pharmaceuticals (EGRX) 1.3M Offering Priced at $42/Share
-
Eagle Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Eagle Pharmaceuticals (EGRX) Commences $50M Stock Offering
-
Rosetta Genomics Reports 2014 Financial Results
-
Eagle Pharmaceuticals Announces Commencement of Public Offering of Common Stock
-
Cantor Fitzgerald Wealth Partners' Pittsburgh Team Recognized by PLANADVISER as One of 2015 Top 100 Retirement Plan Advisors
-
Durect (DRRX) PT Raised to $2.50 at Cantor Fitzgerald
-
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Recent Highlights
-
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Recent Highlights
-
Cantor Fitzgerald Downgrades Pernix Therapeutics (PTX) to Hold on Zohydro Deal
-
Celldex Therapeutics (CLDX) PT Raised to $38 at Cantor Fitzgerald; 2015 Shaping Up to Be Strong
-
Orchid Island Capital Announces March 2015 Monthly Dividend and February 27, 2015 RMBS Portfolio Characteristics
-
Orchid Island Capital Announces March 2015 Monthly Dividend and February 27, 2015 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Europe Establishes Sports Financing Group
-
Helix BioPharma Corp. Announces Q2 Fiscal 2015 Results
-
Wall Street Analysts Weigh in on Apple Watch (AAPL)
-
CCRE Co-CEOs Anthony Orso and Michael Lehrman Ranked No. 1 in "50 Most Important People in Commercial Real Estate Finance" by Mortgage Observer
-
Apple Watch the Most Important Product Event in 5 Years - Cantor Fitzgerald (AAPL)
-
Chimerix (CMRX) Price Target Raised to $57 at Cantor Fitzgerald
-
Tetraphase Pharmaceuticals (TTPH) PT Raised $46 at Cantor Fitzgerald
-
Top Emerging Growth Experts, Investors and Entrepreneurs to Lead Discussion Panels at Growth Capital Expo 2015
-
Jazz Pharmaceuticals (JAZZ) PT Bumped to $175 at Cantor Fitzgerald Amid Positive Xyrem FDA Dispute Resolution
-
Notable Analyst Rating Changes 3/3: (LL) (GPS) (C) Upgraded; (MNKD) (PGN) (MDAS) Downgraded
-
UPDATE: Cantor Fitzgerald Upgrades Durect Corp (DRRX) to Buy on Attractiveness of Pipeline Asset
-
Pre-Open Stock Movers 03/03: (MDR) (FNJN) (DRRX) Higher; (LAYN) (MNKD) (PLUG) Lower (more...)

